Pfizer
EU regulator recommends adding heavy periods to side effects of mRNA COVID shots
Oct 28 (Reuters) - A European Medicines Agency (EMA) committee on Friday recommended adding heavy menstrual bleeding to the list of side…
Pfizer says updated booster protects against circulating COVID variants
Oct 13 (Reuters) - Pfizer Inc and its German partner BioNTech said on Thursday that their Omicron-adapted COVID-19 vaccine booster generated a…
COVID rebound after Pfizer treatment likely due to robust immune response, study finds
(Reuters) - A rebound of COVID-19 symptoms in some patients after taking Pfizer's PFE.N antiviral Paxlovid may be related to a robust…
Pfizer CEO tests positive for COVID
Aug 15 (Reuters) - Pfizer Inc PFE.N Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and…
Pfizer profit surges, reaffirms sales forecast for COVID-19 products
July 28 (Reuters) - Pfizer Inc PFE.N on Thursday reported a 78% jump in profit and reaffirmed the combined 2022 sales forecast…
Pfizer, Moderna to be ready with BA.1-specific COVID boosters
(Reuters) - Pfizer Inc and Moderna Inc said they will be ready with COVID-19 vaccines designed to combat the BA.1 Omicron variant…
FDA staff say Pfizer COVID vaccines safe and effective for small children
(Reuters) - U.S. Food and Drug Administration staff reviewers said Pfizer-BioNTech's COVID-19 vaccines were effective and safe for use in children aged…
Pfizer says COVID treatment Paxlovid fails to prevent infection of household members
Pfizer Inc said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in…
Demand for Pfizer’s COVID pills lags around the world
(Reuters) - Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced…
WHO backs Pfizer’s oral COVID therapy Paxlovid for high-risk patients
The World Health Organization (WHO) endorsed the use of Pfizer Inc's oral COVID-19 antiviral treatment in high-risk patients after an analysis of…
Pfizer COVID vaccine less effective in ages 5-11 -New York study
Two doses of the Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) COVID-19 vaccine was protective against severe disease in children aged 5…
Updated: Pfizer COVID pill Paxlovid gets final approval from European Commission
Jan 28 (Reuters) - The European Commission on Friday approved Pfizer's antiviral pill for COVID-19 a day after the region's health regulator…